Literature DB >> 9783838

Transgenic mice in drug dependence research.

E M Pich1, M P Epping-Jordan.   

Abstract

Transgenic mice with null mutation of specific genes of the central nervous system obtained by homologous recombination, called also knock-out mice, have been recently used by behavioural neuroscientists to understand better the relevance of certain biological mechanisms of drug dependence or addiction. This article reviews some of the main contributions to this fastly developing field. As addictive drugs exert similar reinforcing effects both in humans and other mammals, changes in behavioural performance produced by the motivational effects of the addictive drugs in knock-out mice can give important information about the relevance of that particular gene product (eg a neurotransmitter receptor) for the pathogenicity of substance abuse disorders. In same cases the deletion of a given gene for a neurotransmitter receptor involved in the action of addictive drugs is associated with a phenotype that reproduces the effects obtained by the pharmacological administration of an antagonist for the same receptor. In other instances, surprising results are obtained, the most striking being the evidence that mice lacking the dopamine transporter gene, the most important binding site of cocaine, retain the capability to self-administer cocaine intravenously. Because the gene deletion is operative during embryogenesis, some adaptive compensatory mechanisms may produce unexpected results, suggesting caution in the interpretation of these results. The advent of tissue-specific inducible knock-out mice will soon produce a second revolution in the field of substance abuse research.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9783838     DOI: 10.3109/07853899809029939

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  7 in total

1.  Contributions of A2A and A2B adenosine receptors in coronary flow responses in relation to the KATP channel using A2B and A2A/2B double-knockout mice.

Authors:  Maryam Sharifi Sanjani; Bunyen Teng; Thomas Krahn; Stephen Tilley; Catherine Ledent; S Jamal Mustafa
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-09-23       Impact factor: 4.733

2.  Nucleic acid aptamers for target validation and therapeutic applications.

Authors:  P Shannon Pendergrast; H Nicholas Marsh; Dilara Grate; Judith M Healy; Martin Stanton
Journal:  J Biomol Tech       Date:  2005-09

3.  Up-regulation of A 2B adenosine receptor in A 2A adenosine receptor knockout mouse coronary artery.

Authors:  Bunyen Teng; Catherine Ledent; S Jamal Mustafa
Journal:  J Mol Cell Cardiol       Date:  2008-03-12       Impact factor: 5.000

4.  Pitx3-deficient aphakia mice display unique behavioral responses to psychostimulant and antipsychotic drugs.

Authors:  P A Ardayfio; A Leung; J Park; D-Y Hwang; T Moran-Gates; Y K Choi; W A Carlezon; F I Tarazi; K S Kim
Journal:  Neuroscience       Date:  2009-12-22       Impact factor: 3.590

5.  A single vector containing modified cre recombinase and LOX recombination sequences for inducible tissue-specific amplification of gene expression.

Authors:  S J Kaczmarczyk; J E Green
Journal:  Nucleic Acids Res       Date:  2001-06-15       Impact factor: 16.971

6.  The endogenous cannabinoid anandamide shares discriminative stimulus effects with ∆(9)-tetrahydrocannabinol in fatty acid amide hydrolase knockout mice.

Authors:  D Matthew Walentiny; Thomas F Gamage; Jonathan A Warner; Thanh K Nguyen; Darren B Grainger; Jenny L Wiley; Robert E Vann
Journal:  Eur J Pharmacol       Date:  2011-02-11       Impact factor: 4.432

7.  Unaltered D1, D2, D4, and D5 dopamine receptor mRNA expression and distribution in the spinal cord of the D3 receptor knockout mouse.

Authors:  Hong Zhu; Stefan Clemens; Michael Sawchuk; Shawn Hochman
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2008-09-17       Impact factor: 1.836

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.